UnitedHealth Group Incorporated (UNH) — closed signal from December 19, 2025
Partial Published before the outcome was known, scored automatically when the window closed on March 19, 2026.
Predicted vs. what happened
What happened
Reached 53% of the predicted growth at its peak, without hitting the target.
The thesis — published December 19, 2025
UnitedHealth looks like a short-term rebound after a sharp fall. The company announced operational fixes on 2025-12-19 after outside audits, which could calm investors and reduce some process-related risk. The stock may be undervalued now, but future headlines about regulation or rising medical costs could wipe out the recovery quickly.
Primary drivers
- Operational fixes after audits could steady performance
- Very oversold stock can attract fast buying to cover shorts
- Lower valuation after the drop may draw reversion trades
- Regulatory or medical cost headlines can reverse gains quickly
How it played out
UNH: rebound stalled below target
Lyra published UNH at 331.23 on 2025-12-19 as a short-term rebound idea with 15% expected growth. The thesis pointed to operational fixes after audits, oversold trading, a lower valuation after the drop, and the risk that regulation or medical cost headlines could reverse gains quickly.
Inside the window, UNH rose to 357.87 on 2026-01-23, a peak gain of 8%. It stayed below the 380.91 target. By 2026-03-19, it ended at 280.44. The rebound happened, but not enough to reach the target, and the final price was below the published price. The thesis only partially played out.
What happened during the window
On January 22, 2026, The Guardian reported that UnitedHealth's CEO testified before the House Energy and Commerce Committee during a hearing on rising healthcare costs. On January 27, 2026, MarketWatch reported that health insurer shares fell after CMS proposed a 0.09% Medicare Advantage payment increase for 2027.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.